Nancy Lapid

(Reuters.) – COVID-19 is less likely to cause mild illness than the Omicron version, which has been spreading quickly.

Some may ask why we should go to such lengths to avoid getting infected, when everyone will eventually be exposed.

This is the reason experts don’t think it is time for Omicron to become complacent:

SOMETHING CAN COMMAND YOU TO BE VERY Ill

Omicron could be more likely that it will cause an asymptomatic COVID-19 case than previous variants, according to research. A greater proportion of patients who have signs experience very mild symptoms such as a runny nose or sore throat, but not the severe breathing problems that are common with earlier forms.

Omicron has been spreading rapidly in many countries, so more people may be affected by severe diseases. Particularly, data from Germany and Italy shows that Omicron-infected people are much more susceptible to death, hospitalizations, and intensive care.

Michel Nussenzweig from Rockefeller University, a virus expert, said “I think everyone will be exposed sooner or later.” “Why? Because we’ll have better, more accessible medicines later and better vaccines.”

YOU MAY INFECT OTHERS

Although you might not become seriously ill, you may spread the virus to others, Akiko Iwasaki from Yale University, who is a Yale University researcher in viral immunology.

OMICRON’S LONG TERM EFFECTS ON HUMANITY ARE UNKNOWN

Some cases of long-term COVID syndrome can be caused by infections with older coronavirus variants, such as mild or “breakthrough” cases. Iwasaki explained that we don’t know yet how much Omicron… infection leads to Long COVID. People who consider Omicron a mild infection are at high risk for developing a debilitating condition that could last months to years.

Uncertain is also whether Omicron would have the same “silent effects” as earlier variations, such self-attacking antibodies, sperm impairments or changes in insulin-producing tissues.

MEDICATIONS IN SHORT SUPPLY

Doctors must limit the use of Omicron treatment because they are extremely limited. This variant is incompatible with two of three antiviral drugs that were used to combat it during previous COVID-19 waves. GlaxoSmithKline’s sotrovimab (NYSE:) is out of supply. Also, a new oral antiviral therapy called Paxlovid is not available. Pfizer Omicron seems to have been beaten by Inc (NYSE 🙂 There might not be any treatment options available if you are ill.

HOSPITALS ARE FILLING UP

Omicron is not likely to cause too many problems in fully-vaccinated, boosted people without any underlying conditions. David Ho, Columbia University professor of microbiology, said that Omicron will “not do too much harm” in those who have been fully vaccinated. Ho stated that the less infections the better. This is especially true now because hospitals are overwhelmed and Omicron waves will soon hit the United States.

Hospitals have been forced to delay elective surgery and treatment for cancer due to an unprecedented number of patients infected. In the past, hospitals were unable to treat heart attacks and other emergency situations due to overcrowding.

MORE INFECTIONS MEAN MORE NEW VARIANTS

Omicron represents the fifth most significant variant of SARS COV-2. However, it is not known if this virus’s potential to continue to evolve.

The virus has more chances to evolve and mutate at higher rates than it did before. There is no way to predict if a new coronavirus will be less dangerous or more effective than the ones that have been infected. Ho stated that SARS-CoV-2 had surprised him in many ways during the last two years and that it is impossible to predict the evolution of the virus’s evolutionary path.